tailieunhanh - HARRISON’S Hematology and Oncology

Harrison’s Principles of Internal Medicine has a long and dis- tinguished tradition in the field of hematology. Maxwell Wintrobe, whose work actually established hematology as a distinct subspecialty of medicine, was a founding editor of the book and participated in the first seven edi- tions, taking over for Tinsley Harrison as editor-in-chief on the sixth and seventh editions. Wintrobe, born in 1901, began his study of blood in earnest in 1927 as an assistant in medicine at Tulane University in New continued his studies at Johns Hopkins from 1930 to 1943 and moved to the University of Utah in 1943, where he remained until his death in. | HARRISON S Hematology and Oncology HARRISON S Hematology and Oncology Derived from Harrison s Principles of Internal Medicine 17th Edition Editors ANTHONY S. FAUCI MD Chief Laboratory of Immunoregulation Director National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda DENNIS L. KASPER MD William Ellery Channing Professor of Medicine Professor of Microbiology and Molecular Genetics Harvard Medical School Director Channing Laboratory Department of Medicine Brigham and Women s Hospital Boston DAN L. LONGO MD Scientific Director National Institute on Aging National Institutes of Health Bethesda and Baltimore EUGENE BRAUNWALD MD Distinguished Hersey Professor of Medicine Harvard Medical School Chairman TIMI Study Group Brigham and Women s Hospital Boston STEPHEN L. HAUSER MD Robert A. Fishman Distinguished Professor and Chairman Department of Neurology University of California San Francisco J. LARRY JAMESON MD PhD Professor of Medicine Vice President for Medical Affairs and Lewis Landsberg Dean Northwestern University Feinberg School of Medicine Chicago JOSEPH LOSCALZO MD PhD Hersey Professor of Theory and Practice of Medicine Harvard Medical School Chairman Department of Medicine Physician-in-Chief Brigham and Women s Hospital .

• Y học thường thức
• CARDINAL MANIFESTATIONS
• HEMATOLOGIC DISEASE
• DISORDERS
• HEMOSTASIS
• ANEMIAS
• CANCER PREVENTION
• TREATMENT
• ENDOCRINE NEOPLASIA
• Harrisons hematology and oncology
• The cellular basis of hematopoiesis
• Cardinal manifestations of hematologic disease
• Myeloproliferative disorders
• Hematologic malignanciesc
• Biology of cance
• Harrisons principles of internal medicine
• General considerations in clinical medicine
• Presentation of diseases
• The environment and disease
• Regenerative medicine
• Introduction to clinical medicine
• The environment
• Genetic testing identifies the potential risk
• Mltiple endocrine neoplasia
• High risk group
• Medullary thyroid carcinoma guidelines
• Multiple endocrine neoplasia type 2A
• BMC Cancer
• Multiple endocrine neoplasia type 1 syndrome
• Carcinoid tumor
• Skeletal metastasis
• Neuroendocrine tumors
• Primary hyperparathyroidism
• BMC Pediatrics
• Multiple endocrine neoplasia 2B
• Medullary thyroid carcinoma
• Multiple mucosal neuroma
• Hirschsprung disease
• Proto oncogene
• Multiple endocrine neoplasia type 1
• Multidisciplinary investigations
• Functioning glucagonoma
• RET proto oncogene
• Multiple endocrine neoplasia type 2
• Medullary thyroid cancer
• Genetic variants
• RET variants
• báo cáo khoa học
• báo cáo y học
• công trình nghiên cứu về y học
• tài liệu về y học
• cách trình bày báo cáo
• Tạp chí y học
• Nghiên cứu y khoa
• Tuyến thượng thận
• Đa bướu nội tiết
• Bướu sắc bào tủy tuyến thượng thận
• Essential endocrinology and diabetes
• Essential endocrinology
• Gastrointestinal endocrinology
• Metabolic bone disorders
• Diabetes and obesity
• Thyroid cancer
• Latin America
• Frequent endocrine neoplasia worldwide
• Pathological variants